Diaceutics (GB:DXRX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Diaceutics PLC is expanding its US commercial activities by executing multiple data partnership agreements, contributing to a first-year contract value of £1.13 million. These partnerships are expected to increase revenue and Annual Recurring Revenue by leveraging partner sales teams to sell high-margin data products like DXRX Signal. The company aims to broaden its customer base, tapping into new segments and pharmaceutical brands.
For further insights into GB:DXRX stock, check out TipRanks’ Stock Analysis page.